These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 17218415

  • 1. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
    Hirono Y, Yoshimoto T, Suzuki N, Sugiyama T, Sakurada M, Takai S, Kobayashi N, Shichiri M, Hirata Y.
    Endocrinology; 2007 Apr; 148(4):1688-96. PubMed ID: 17218415
    [Abstract] [Full Text] [Related]

  • 2. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
    Yu Y, Fukuda N, Yao EH, Matsumoto T, Kobayashi N, Suzuki R, Tahira Y, Ueno T, Matsumoto K.
    Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
    Minas JN, Thorwald MA, Conte D, Vázquez-Medina JP, Nishiyama A, Ortiz RM.
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K, Sasamura H, Sakamaki Y, Itoh H, Saruta T.
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH, Chang YS.
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
    Wang H, Shimosawa T, Matsui H, Kaneko T, Ogura S, Uetake Y, Takenaka K, Yatomi Y, Fujita T.
    J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
    [Abstract] [Full Text] [Related]

  • 13. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, Hamoud S, Aviram M.
    Circulation; 2004 May 11; 109(18):2213-20. PubMed ID: 15123520
    [Abstract] [Full Text] [Related]

  • 14. Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.
    Zhou MS, Schulman IH, Raij L.
    Am J Physiol Heart Circ Physiol; 2009 Mar 11; 296(3):H833-9. PubMed ID: 19151253
    [Abstract] [Full Text] [Related]

  • 15. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ, Mogi M, Iwanami J, Li JM, Sakata A, Fujita T, Tsukuda K, Iwai M, Horiuchi M.
    Cardiovasc Res; 2007 Dec 01; 76(3):506-16. PubMed ID: 17706954
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of reactive oxygen species in hypothalamic paraventricular nucleus attenuates the renin-angiotensin system and proinflammatory cytokines in hypertension.
    Su Q, Qin DN, Wang FX, Ren J, Li HB, Zhang M, Yang Q, Miao YW, Yu XJ, Qi J, Zhu Z, Zhu GQ, Kang YM.
    Toxicol Appl Pharmacol; 2014 Apr 15; 276(2):115-20. PubMed ID: 24576725
    [Abstract] [Full Text] [Related]

  • 17. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
    Onozato ML, Tojo A, Kobayashi N, Goto A, Matsuoka H, Fujita T.
    Nephrol Dial Transplant; 2007 May 15; 22(5):1314-22. PubMed ID: 17324946
    [Abstract] [Full Text] [Related]

  • 18. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K, Kobara M, Hamada J, Yoshifuji Y, Shiraishi T, Tanaka T, Wang J, Toba H, Nakata T.
    J Cardiovasc Pharmacol; 2012 Aug 15; 60(2):140-9. PubMed ID: 22549451
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
    Whaley-Connell A, Govindarajan G, Habibi J, Hayden MR, Cooper SA, Wei Y, Ma L, Qazi M, Link D, Karuparthi PR, Stump C, Ferrario C, Sowers JR.
    Am J Physiol Endocrinol Metab; 2007 Jul 15; 293(1):E355-63. PubMed ID: 17440033
    [Abstract] [Full Text] [Related]

  • 20. Aldosterone causes vasoconstriction in coronary arterioles of rats via angiotensin II type-1 receptor: influence of hypertension.
    Kushibiki M, Yamada M, Oikawa K, Tomita H, Osanai T, Okumura K.
    Eur J Pharmacol; 2007 Oct 31; 572(2-3):182-8. PubMed ID: 17644087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.